Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: 4 | Vintage Vibes

US FDA Approves Wegovy To Cut Risk Of Heart Problems

The US Food and Drug Administration has given the green light for a popular anti-obesity drug to be used to prevent serious heart conditions for the first time, in a move likely to expand insurance coverage.

International Business Times · Mar 8, 2024

Jumpstart Your Portfolio With These 3 Biotech Stocks

The biotech industry’s robust growth potential is fueled by scientific advancements, rapid technological adoption, and supportive government initiatives. Thus, you could consider investing in top biotech stocks Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Vanda Pharmaceuticals (VNDA) to strengthen your portfolio. Keep reading….

StockNews.com · Feb 26, 2024

Acetaminophen Use During Pregnancy Linked To Language Delays In Early Childhood: Study

The study does not prove a causative relationship between acetaminophen usage in pregnancy and language delay in children. More research is required to understand if other factors are involved.

Medical Daily · Dec 22, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA Spots Control Irregularities in Moderna's US Plant

Dive into the intriguing saga of unanticipated control failures at Moderna's magnate production plant, a juicy scoop exclusively unraveled by the meticulou...

Philips Stock Slumps After New FDA Warning

Shares in Dutch medical device manufacturer Philips plunged Wednesday after the US Food and Drug Administration warned that its new machine to help patients sleep risked overheating.

International Business Times · Nov 29, 2023

'Gas Station Heroin' Supplement Causes Seizures, Loss Of Consciousness, FDA Warns

Neptune's Fix, a product sold illegally with claims to improve brain function and treat conditions such as anxiety, depression, pain and opioid use disorder, contains a potentially dangerous substance called tianeptine.

Medical Daily · Nov 27, 2023

High silver levels in some period pants could pose health risk, study says

Women warned to consider potential effect of wearing brands that contain notably higher quantities of metal

The Guardian - UK · Nov 13, 2023

Read news from The Economist, FT, and more,
with one subscription

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients

The Independent UK · Nov 11, 2023

The FDA proposes banning a food additive that's been used for a century

Brominated vegetable oil is a food additive that studies show causes organ damage in rats and pigs. It was introduced in the 1920s and is used today in sodas and sports drinks.

WEKU · Nov 3, 2023

Popular nasal decongestant found to be ineffective by US drugs regulator – what it means for the UK

An advisory panel of the US Food and Drug Administration has found that a drug used in the majority of cold and flu products to treat blocked noses does not work.

The Conversation · Oct 20, 2023

Ozempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study suggests

The study represents the first long-term, large-scale, real-world trial of the blockbuster drug, researchers said.

Fortune · Oct 2, 2023

TikTok videos promoting steroid use have millions of views, says report criticized by the company

A report released by a tech watchdog group says TikTok has become a key marketing channel for vendors that want to promote steroids and other bodybuilding drugs to millions of the app's users

The Independent UK · Sep 28, 2023

US FDA approves new COVID vaccine: Here’s everything you need to know

The US Food and Drug Administration (FDA) has taken cognizance of the COVID situation and has approved the use of updated COVID vaccines. The vaccines have been authorized "for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences…

The Times of India · Sep 15, 2023

What to know about Prime, the Logan Paul drink that Sen. Schumer wants investigated

Prime drinks have become a Gen Z status symbol, a prized social media prop for a certain brand of teen male. But they're causing jitters among pediatricians who say they pack scary caffeine levels.

WEKU · Jul 11, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

The Times of India · Jul 6, 2023

New blood test can detect high blood pressure in moms during pregnancy

The US Food and Drug Administration has approved a blood test that can identify pregnant women at risk of developing high blood pressure, the NYTimes reported. This condition, called as pre-eclampsia, is one of the leading causes of death among women. "The new test may offer an early warning, identifying…

StockNews.com · Jun 15, 2023

3 Pharma Stocks Every Investor Should Know

The pharma sector is poised to witness significant growth due to the widespread adoption of generic medicines and emerging technologies. Therefore, fundamentally strong pharma stocks Pfizer (PFE), Sanofi (SNY), and Spero Therapeutics (SPRO) might be solid buys. Read on.

The Conversation · May 9, 2023

RSV: we finally have a vaccine for this deadly virus

The first vaccine against respiratory syncytial virus (RSV) has been approved by the US Food and Drug Administration. The vaccine, named Arexvy, will be given to people 60 years and older.

The Independent UK · Apr 28, 2023

State lawmakers across US pass 1 abortion ban but 2 defeated

With measures to protect abortion access becoming law in two states, a ban in a third state and court action elsewhere, the status of abortion law in the U.S. remains unsettled

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Apr 27, 2023

Vermont passes bills aimed at protecting abortion pills

The Vermont Legislature has passed reproductive and gender-affirming health care bills with a late addition aimed at protecting access to a medication widely used in abortions — even if the U.S. Food and Drug Administration withdraws its approval of mifepristone

The Conversation · Apr 26, 2023

Challenging the FDA's authority isn't new – the agency's history shows what's at stake when drug regulation is in limbo

Political pressure is nothing new for the U.S. Food and Drug Administration. The agency has frequently come under fire for its drug approval decisions, but attacks on its decision-making process and science itself have increased during the COVID-19 pandemic.

Tribune News Service · Apr 11, 2023

US seeks freeze on Texas abortion pill ruling, clarity on conflicting order

WASHINGTON — The Biden administration asked a federal appeals court to suspend a ruling by a conservative U.S. judge in Texas that would block access nationwide to a key drug used in medication abortions — even as it sought clarity on a conflicting order in Washington state.

StockNews.com · Mar 29, 2023

3 of the Best Stocks in 1 of Wall Street's Worst-Rated Industry

After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…

StockNews.com · Mar 7, 2023

4 Stocks to Buy in Any Market Climate

The stock market is expected to remain volatile in the near term as investors remain anxious about the Fed’s actions. Amid high recession worries, fundamentally strong healthcare stocks, Pfizer (PFE), Bristol-Myers Squibb (BMY), Amgen (AMGN), and Elevance Health (ELV), which have the potential to withstand any market downturns, could be…

StockNews.com · Mar 2, 2023

2 Pharma Stocks to Buy Right Now and 1 You Might Want to Consider Selling

The pharmaceutical industry is evolving with personalized medicines and the rapid adoption of RPM technology, which should boost growth. Moreover, with a recession lurking, fundamentally strong pharma stocks AstraZeneca (AZN) and Bristol-Myers Squibb (BMY) might be ideal buys. However, SNDL (SNDL) might be best avoided. Keep reading to know why.

WEKU · Feb 21, 2023

The maker of Enfamil recalls 145,000 cans of infant formula over bacteria risks

Reckitt says despite contamination fears, the recalled formula tested negative for Cronobacter, which can cause rare but deadly infections in infants. Here's how to identify and prevent them.

1 … 3 4 5 6

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.